Apr 10 |
vTv Therapeutics files $250M mixed securities shelf
|
Mar 19 |
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
|
Mar 13 |
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
|
Mar 4 |
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
|
Mar 4 |
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
|
Mar 1 |
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
|
Feb 28 |
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Feb 28 |
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
|
Feb 22 |
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
|
Nov 29 |
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|